MedTrace Logo

Probiotic Treatment in Adult Obsessive-Compulsive Disorder

NCT02334644 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-09-10

No results posted yet for this study

Summary

This study will evaluate the effectiveness of 12-weeks of probiotic treatment in adults with primary Obsessive-Compulsive Disorder and whether this treatment will alter the microbiota composition in these patients.

Conditions

  • Obsessive-Compulsive Disorder

Interventions

DIETARY_SUPPLEMENT

Probiotic Formula (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175)

2 sachets/day x 12 weeks

DIETARY_SUPPLEMENT

Placebo

2 sachets/day x 12 weeks

Sponsors & Collaborators

  • Hamilton Health Sciences Corporation

    collaborator OTHER

  • Lallemand Health Solutions

    collaborator INDUSTRY

  • McMaster University

    lead OTHER

Principal Investigators

  • Michael Van Ameringen, MD, FRCPC · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02334644 on ClinicalTrials.gov